Table 3 Subgroups analysis – depending on occurrence of additional malignancies

Gender

Women

334 (51%)

55 / 44%

279 / 52%

0,03967^*

Men

310 (48%)

71 / 56%

239 / 48%

Age (years)

Median

62

67

61

0,00004**

Mean (± SD)

61

66,29 (± 10,95)

59,77 (± 12,71)

Tumours largest basal diameter (mm)

Mean (± SD)

12,24

12,24 ± 3,72

12,23 ± 3,21

0,98401**

Tumours height (mm)

Mean (± SD)

7,57

7,74 ± 2,41

7,52 ± 3,21

0,5706**

Histological type

Epithelial cell

66 /16%

15 / 19%

51 / 16%

0,28748*

Spindle cell

177 / 44%

39 / 49%

138 / 43%

Mixed cell

158 / 39%

25 / 32%

133 / 41%

TNM (8th ed) ( No. of patients / % of patients)

T1

96 / 15%

19 / 15%

77 / 15%

0,96851*

T2

222 / 34%

43 / 34%

179 / 34%

T3

226 / 35%

46 / 37%

180 /34%

T4

100 / 16%

18 / 14%

82 / 16%

Stage (8th ed) ( No. of patients / % of patients)

I

76 / 11,8%

14 / 11%

62 / 12%

0,69927*

IIA

198 / 30,7%

44 / 35%

154 / 29%

IIB

185 / 28,7%

37 / 29%

148 / 28%

IIIA

143 / 22,2%

26 / 21%

117 / 22%

IIIB

39 / 6,1%

5 / 4%

34 / 6%

IIIC

3 / 0,5%

-

3 / 1%

Hypertension ( No. of patients / % of patients)

Yes

251 / 39%

49 / 39%

202 / 39%

0,87168*

No

334 / 52%

67 / 53%

267 / 51,5%

Unknown status

59 / 9%

10 / 8%

49 / 9,5%

Diabetes Mellitus ( No. of patients / % of patients)

Yes

82 / 13%

14 / 11%

68 / 13%

0,69107*

No

490 / 76%

100 / 79%

390 / 75%

Unknown status

72 / 11%

12 / 10%

60 / 12%